Mitsikostas, Dimos D. http://orcid.org/0000-0002-4691-3388
Blease, Charlotte
Carlino, Elisa
Colloca, Luana
Geers, Andrew L.
Howick, Jeremy
Evers, Andrea W. M.
Flaten, Magne A.
Kelley, John M.
Kirsch, Irving
Klinger, Regine
MaassenVanDenBrink, Antoinette
Moerman, Daniel E.
Sfikakis, Petros P.
Vase, Lene
Wager, Tor D.
Benedetti, Fabrizio
,
Article History
Received: 28 July 2020
Accepted: 26 August 2020
First Online: 25 September 2020
Ethics approval and consent to participate
: Ethics approval and consent to participate was not needed for this position article.
: All authors have reviewed the final version and gave their approval for publication.
: Authors, Financial disclosure (consulting, speaking fees, travel grants, research support).Dimos D. Mitsikostas: Allergan, Amgen, Bayer, Biogen, Cefaly, Electrocore, Genesis Pharma, Eli Lily, Merck-Serono, Merz, Sanofi-Genzyme, Roche, Specifar, Teva.Charlotte Blease reports no competing interests.Elisa Carlino reports no competing interests.Luana Colloca reports no competing interests.Andrew L. Geers reports no competing interests.Jeremy Howick reports no competing interests.Andrea WM Evers reports no competing interests.Magne A. Flaten reports no competing interests.John M. Kelley reports no competing interests.Irving Kirsch reports no competing interests.Regine Klinger reports no competing interests.Antoinette Maassen van den Brink: Allergan, Amgen/Novartis, Lilly, Teva.Daniel E. Moerman reports no competing interests.Petros P. Sfikakis reports no competing interests.Lene Vase reports no competing interests.Tor D. Wager reports no competing interests.Fabrizio Benedetti reports no competing interests.